Kei Muro

Aichi Cancer Center ORCID: 0000-0002-5572-743X

1

h-index

1

Publications

1,096

Citations

Publications

1 shown

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial

Kei Muro , Hyun Cheol Chung , Veena Shankaran +15 more

2016 The Lancet Oncology 1096 citations

Frequent Co-Authors

Hyun Cheol Chung

Yonsei University

Veena Shankaran

University of Washington

Ravit Geva

Sheba Medical Center

Daniel V.T. Catenacci

University of Chicago

Shilpa Gupta

Sheba Medical Center

Joseph P. Eder

Yale University

Researcher Info

h-index: 1
Publications: 1
Citations: 1,096
Institution: Aichi Cancer Center

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-5572-743X

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.